In a cross-sectional study of 139 patients with CKD, serum levels of NAM and NMN decreased, while levels of N-Me-2PY and N-Me-4PY increased with progressive renal dysfunction [72]. This evidence concerns the gene STAC3 and chronic kidney disease.